3D MEDICINES: Annual Report 2024

HKEXApr 30 04:41 ET · Announcements

3D Medicines Inc.'s (HKG:1244) Shares Leap 30% Yet They're Still Not Telling The Full Story

Simply Wall StApr 5 20:42 ET

Investors who bought high-level pharmaceutical Funds have hope! More than 80% of products achieved positive returns in the first quarter, and recovering losses is promising.

① A total of 264 medical Funds had positive returns in the first quarter of this year, accounting for over 80%, with many Funds achieving returns exceeding 15% this year. ② The net value of medical Funds established in 2020 and 2021 is currently being repaired, and investors who entered at high levels are expected to break even.

cls.cnApr 1 03:04 ET

3D Medicines' 2024 Loss Narrows, Revenue Drops 30%

MT NewswiresMar 31 23:14 ET

3D Medicines Inc. Forms Nomination Committee for Enhanced Governance

TipRanksMar 31 11:26 ET

Express News | 3D Medicines FY Revenue RMB 445.6 Million

ReutersMar 31 10:49 ET